Survival rate of all cardiac arrest victims. This includes those with a "workable" rhythm, such as V-Fib and V-Tach, as well as Asystole (flatline) and arrests caused by trauma, including those that are discontinued on the scene without transport to the hospital. This is based upon the ROSC (return of spontaneous circulation) of all patients with full cardiac arrest as found prior to transfer to the Hospital Emergency Department.

We completed the training on the Elegard heads up CPR device during the first week of December 2019 and began the testing of the new device and procedures.  We are part of a national trial of this device, along with several other departments across the Country.  This process involves the use of the Elegard device, which raises the patients head during CPR to improve intracranial pressure which can imrpove oxygen flow to the brain and improve long term patient survival.  This process includes other adjuncts, such as rthe LUCAS mechanical CPR device, ResQPods, capnography, and airway modifications, as well as process improvements that we have been making over the years.  Thus far, the results have been promising, but it is too early to evaluate the overall impact of the changes.  WHile thes results from the last quarter exceed the target, this measure is somewhat cyclical as it can fluctuate greatly depending upon the number of cardiac arrests and the condition of the patient upon our arrival, since we count all cardiac arrests.